Why Key Antiviral Defenses Fail in Severe COVID-19 Patients
Research published in the journal Cell reveals that severe COVID-19 cases are often linked to pre-existing autoantibodies that neutralize type I interferons. According to findings from a global consortium of researchers, these autoantibodies are produced by a mature population of B cells that exist before viral exposure, effectively disabling the body’s primary antiviral alarm system. … Read more